ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch
By filer · By stock

$CVRX:NASDAQ · Cvrx Inc - US

Baroreflex neuromodulation for heart failure

Sector: health

Conviction from: NASDAQCitrini

52-week range: 2.2011.30

2 tracked filer(s) hold this · 1 opened, 1 added, 0 trimmed in 30-JUN-2026

Aggregate 13FScore 72 — mean of 2 scored holder(s) · buyers (new/add) avg 72. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7280New buy26,773$137,6130.0%
Paul Tudor Jones / Tudor63Added +4%205,684$1,057,2160.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-02-23Jain Mudit K.director46,800$297,648Form 4

Citrini Research coverage report library →

ReportDateStance
#110 — I Can See Clearly Now... The Rain Is Gone?2025-11-03LONG
#104 — State of the Themes: Long GOOGL, Asian Outperformance and the Age of Virality2025-08-18LONG
#92 — Market Memo: Talk to Me, Goose2025-04-13LONG
#80 — Market Memo: January Musings2025-01-09LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.